Tweet
I'm a graduate student in Bioinformatics at Boston University. I'm with the graduate partnership with NIH so I'm doing my thesis at the National Cancer Institute. I'm working on miRNA profiling in neuroblastoma samples using nextgen technology. I have Solexa data and our lab is getting a Solid machine to test out, so I'll have a lot more data coming.
-
Wes Beckstead
Predoctoral Fellow in Bioinformatics
Boston University Partnership with NIH
[email protected]
-
Proteins are often described as the workhorses of the cell, and identifying their sequences is key to understanding their role in biological processes and disease. Currently, the most common technique used to determine protein sequences is mass spectrometry. While still a valuable tool, mass spectrometry faces several limitations and requires a highly experienced scientist familiar with the equipment to operate it. Additionally, other proteomic methods, like affinity assays, are constrained...04-04-2024, 04:25 PM -
Despite advancements in sequencing platforms and related sample preparation technologies, certain sample types continue to present significant challenges that can compromise sequencing results. Pedro Echave, Senior Manager of the Global Business Segment at Revvity, explained that the success of a sequencing experiment ultimately depends on the amount and integrity of the nucleic acid template (RNA or DNA) obtained from a sample. “The better the quality of the nucleic acid isolated...03-22-2024, 06:39 AM